MR

Marie-Odile Roy

OS Ogeda Sa: 6 patents #4 of 10Top 40%
ES Euroscreen S.A.: 4 patents #21 of 56Top 40%
IR Irm: 1 patents #133 of 277Top 50%
NA Novartis Ag: 1 patents #2,882 of 5,128Top 60%
SR Scripps Research: 1 patents #709 of 1,293Top 55%
Overall (All Time): #501,530 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
10941151 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Hamid R. Hoveyda, Guillaume Dutheuil, Graeme L. Fraser, Mohamed El Bousmaqui, Frederic Batt 2021-03-09
10683295 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Hamid R. Hoveyda, Guillaume Dutheuil, Graeme L. Fraser, Mohamed El Bousmaqui, Frederic Batt 2020-06-16
10544150 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Hamid R. Hoveyda, Graeme L. Fraser, Guillaume Dutheuil 2020-01-28
10065961 Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Hamid R. Hoveyda, Guillaume Dutheuil, Graeme L. Fraser, Mohamed El Bousmaqui, Frederic Batt 2018-09-04
10065960 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Hamid R. Hoveyda, Graeme L. Fraser, Guillaume Dutheuil 2018-09-04
9926325 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Hamid R. Hoveyda, Graeme L. Fraser, Guillaume Dutheuil 2018-03-27
9475814 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Hamid R. Hoveyda, Guillaume Dutheuil, Graeme L. Fraser, Mohamed El Bousmaqui, Frederic Batt 2016-10-25
8871761 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Hamid R. Hoveyda, Graeme L. Fraser, Guillaume Dutheuil 2014-10-28
8497075 Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands Birgit Baumgarten, Francois Gessier, Andreas Katopodis, Richard Knochenmuss, Rocco Falchetto +11 more 2013-07-30
7824866 Ligand for G-protein coupled receptor GPR72 and uses thereof Sebastien Hannedouche 2010-11-02